Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adaptive, Randomized, Non-inferiority Trial on the Use of Monoclonal Antibodies or Antivirals in Outpatients With Mild or Moderate COVID-19

NCT05321394 is registered in ClinicalTrials.gov with Azienda Ospedaliera Universitaria Integrata Verona as lead sponsor.

NCT NCT05321394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05321394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adaptive, Randomized, Non-inferiority Trial on the Use of Monoclonal Antibodies or Antivirals in Outpatients With Mild or Moderate COVID-19
Lead sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Phase
Phase 3
Overall status
Completed
Start date
March 7, 2022
Completion date
October 29, 2023
Enrollment
536 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19